For the first part of the application process, the MedTech Actuator team will be assessing applications internally. If asked to provide further information for due diligence, MedTech Actuator partners, including MinterEllison and FBRice, will provide services to assist the team.

Startups that get through to the next round will undergo deep due diligence and will be required to pitch – with Q&A – to our Innovation Assessment Board,  made up of our global corporate partners, clinical partners, product development partners and legal partners.